Trials / Completed
CompletedNCT03465189
Validation of a Seizure Monitoring System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- St Vincent's Hospital Melbourne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aim to determine the feasibility of using the Medtronic LINQ device for epilepsy diagnosis, monitoring and management. The feasibility will be determined by comparing EEG signals from the LINQ system to the gold standard clinical recordings. If seizures can be identified using the LINQ device with the same level of accuracy as adjacent scalp EEG recording electrodes, then the LINQ will be deemed feasible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medtronic LINQ Device | Using two LINQ devices that are fixed to scalp to record EEG (in addition to the standard scalp EEG). |
Timeline
- Start date
- 2018-09-10
- Primary completion
- 2019-03-19
- Completion
- 2020-03-19
- First posted
- 2018-03-14
- Last updated
- 2020-10-27
Locations
1 site across 1 country: Australia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03465189. Inclusion in this directory is not an endorsement.